- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 115,244,363
- Total 13F shares
- 111,055,346
- Share change
- +48,750
- Total reported value
- $9,704,160,249
- Put/Call ratio
- 43%
- Price per share
- $87.31
- Number of holders
- 556
- Value change
- +$149,786,841
- Number of buys
- 256
- Number of sells
- 268
Quarterly Holders Quick Answers
What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 379577208:
Top shareholders of GMED - GLOBUS MEDICAL INC - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
9.1%
|
10,487,237
|
$778,991,964 | -$11,095,352 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.2%
|
10,605,747
|
$607,391,131 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
6.1%
|
7,029,294
|
$522,135,958 | +$30,787,723 | 31 Mar 2025 | |
| Burgundy Asset Management Ltd. |
13F
|
Company |
3%
|
3,460,983
|
$212,054,428 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.2%
|
3,681,957
|
$210,865,683 | — | 30 Sep 2025 | |
| Sculptor Capital LP |
13F
|
Company |
3%
|
3,500,000
|
$200,445,000 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
3,461,610
|
$198,246,405 | — | 30 Sep 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,819,165
|
$161,453,580 | — | 30 Sep 2025 | |
| Madison Avenue Partners, LP |
13F
|
Company |
2.2%
|
2,548,163
|
$145,933,295 | — | 30 Sep 2025 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
2,083,939
|
$119,347,176 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,062,975
|
$118,168,087 | — | 30 Sep 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.8%
|
2,055,183
|
$117,700,330 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
2,011,104
|
$115,166,469 | — | 30 Sep 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.5%
|
1,777,431
|
$101,793,000 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.5%
|
1,711,909
|
$98,041,030 | — | 30 Sep 2025 | |
| HAWK RIDGE CAPITAL MANAGEMENT LP |
13F
|
Company |
1.4%
|
1,569,235
|
$89,870,088 | — | 30 Sep 2025 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
1.3%
|
1,446,614
|
$82,847,584 | — | 30 Sep 2025 | |
| Van Berkom & Associates Inc. |
13F
|
Company |
1.2%
|
1,333,111
|
$76,347,000 | — | 30 Sep 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
1.1%
|
1,288,128
|
$73,771,091 | — | 30 Sep 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.1%
|
1,250,000
|
$71,587,500 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
1,203,708
|
$68,936,357 | — | 30 Sep 2025 | |
| AXA Investment Managers S.A. |
13F
|
Company |
1%
|
1,202,828
|
$68,885,959 | — | 30 Sep 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1%
|
1,202,488
|
$68,866,488 | — | 30 Sep 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
1%
|
1,185,461
|
$67,891,352 | — | 30 Sep 2025 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
0.99%
|
1,145,591
|
$65,607,997 | — | 30 Sep 2025 | |
| Parsifal Capital Management, LP |
13F
|
Company |
0.96%
|
1,104,332
|
$63,245,094 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.95%
|
1,091,732
|
$62,525,000 | — | 30 Sep 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.88%
|
1,019,317
|
$58,376,285 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.86%
|
993,120
|
$56,877,000 | — | 30 Sep 2025 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
0.82%
|
946,800
|
$54,223,236 | — | 30 Sep 2025 | |
| ANTIPODES PARTNERS Ltd |
13F
|
Company |
0.77%
|
891,043
|
$51,033,882 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.75%
|
865,556
|
$49,570,392 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
861,692
|
$49,349,102 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.73%
|
841,004
|
$48,164,337 | — | 30 Sep 2025 | |
| ANCHOR CAPITAL ADVISORS LLC |
13F
|
Company |
0.69%
|
800,282
|
$45,832,141 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.67%
|
767,561
|
$43,958,192 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.66%
|
757,529
|
$43,383,603 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.66%
|
756,221
|
$43,308,777 | — | 30 Sep 2025 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.63%
|
728,438
|
$41,717,644 | — | 30 Sep 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.62%
|
718,060
|
$41,123,296 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.62%
|
709,633
|
$40,640,682 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
695,358
|
$39,823,152 | — | 30 Sep 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.59%
|
681,898
|
$39,052,298 | — | 30 Sep 2025 | |
| Swedbank AB |
13F
|
Company |
0.59%
|
679,075
|
$38,890,625 | — | 30 Sep 2025 | |
| Paradice Investment Management LLC |
13F
|
Company |
0.58%
|
663,038
|
$37,972,186 | — | 30 Sep 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.51%
|
592,891
|
$33,954,867 | — | 30 Sep 2025 | |
| Capital World Investors |
13F
|
Company |
0.5%
|
574,500
|
$32,901,615 | — | 30 Sep 2025 | |
| Pembroke Management, LTD |
13F
|
Company |
0.49%
|
562,190
|
$32,196,621 | — | 30 Sep 2025 | |
| Bares Capital Management, Inc. |
13F
|
Company |
0.45%
|
521,129
|
$29,845,058 | — | 30 Sep 2025 | |
| SIRIOS CAPITAL MANAGEMENT L P |
13F
|
Company |
0.45%
|
514,778
|
$29,481,336 | — | 30 Sep 2025 |
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2025
As of 31 Dec 2025,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
556 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,055,346 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., JANUS HENDERSON GROUP PLC, Invesco Ltd., STATE STREET CORP, BANK OF MONTREAL /CAN/, JPMORGAN CHASE & CO, Sculptor Capital LP, Madison Avenue Partners, LP, and CITADEL ADVISORS LLC.
This page lists
556
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
488
Q4 2025 holders
556
Holder diff
68
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.